Your browser doesn't support javascript.
loading
HIV medical care interruption among people living with HIV in Spain, 2004-2020.
Izquierdo, Rebeca; Rava, Marta; Moreno-García, Estela; Blanco, José Ramón; Asensi, Víctor; Cervero, Miguel; Curran, Adrian; Rubio, Rafael; Iribarren, José Antonio; Jarrín, Inmaculada.
Afiliação
  • Izquierdo R; National Center for Epidemiology, Instituto de Salud Carlos III.
  • Rava M; Centre of Biomedical Research for Infectious Diseases (CIBERINFEC), Madrid.
  • Moreno-García E; National Center for Epidemiology, Instituto de Salud Carlos III.
  • Blanco JR; Centre of Biomedical Research for Infectious Diseases (CIBERINFEC), Madrid.
  • Asensi V; Infectious Diseases Department, Hospital Universitario de Navarra, Pamplona.
  • Cervero M; Infectious Diseases Department, Hospital San Pedro-CIBIR, Logroño.
  • Curran A; Infectious Diseases - HIV Unit, Internal Medicine, Hospital Universitario Central de Asturias, Oviedo University School of Medicine, Translational Research in Infective Pathology Lab, ISPA-FINBA.
  • Rubio R; Internal Medicine Department, Hospital Universitario Severo Ochoa, Leganés.
  • Iribarren JA; Infectious Diseases Department, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute, Barcelona.
  • Jarrín I; HIV Unit, Internal Medicine Department, Biomedical Research Institute Imas12, Hospital Universitario 12 de Octubre. Medicine Department. Universidad Complutense de Madrid, Madrid.
AIDS ; 37(8): 1277-1284, 2023 07 01.
Article em En | MEDLINE | ID: mdl-36939068
OBJECTIVE: We estimated the incidence rate of HIV medical care interruption (MCI) and its evolution over a 16-year-period, and identified associated risk factors among HIV-positive individuals from the Cohort of the Spanish AIDS Research Network in 2004-2020. DESIGN: We included antiretroviral-naive individuals aged at least 18 years at enrolment, recruited between January 1, 2004, and August 30, 2019, and followed-up until November 30, 2020. METHODS: Individuals with any time interval of at least 15 months between two visits were defined as having a MCI. We calculated the incidence rate (IR) of having at least one MCI and used multivariable Poisson regression models to identify associated risk factors. RESULTS: Of 15 274 individuals, 5481 (35.9%) had at least one MCI. Of those, 2536 (46.3%) returned to HIV care after MCI and 3753 (68.5%) were lost to follow-up at the end of the study period. The incidence rate (IR) of MCI was 7.2/100 person-years (py) [95% confidence interval (CI): 7.0-7.4]. The annual IR gradually decreased from 20.5/100 py (95% CI: 16.4-25.6) in 2004 to 4.9/100 py (95% CI: 4.4-5.5) in 2014, a slight increase was observed between 2015 and 2018, reaching 9.3/100 py (95% CI: 8.6-10.2) in 2019. Risk factors for MCI included younger age, lower educational level, having contracted HIV infection through injecting drug use or heterosexual intercourse, having been born outside of Spain, and CD4 + cell count >200 cell/µl, viral load <100 000 and co-infection with hepatitis C virus at enrolment. CONCLUSIONS: Around a third of individuals had at least one MCI during the follow-up. Identified predictors of MCI can help health workers to target and support most vulnerable individuals.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Hepatite C Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Hepatite C Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2023 Tipo de documento: Article